secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2026-08-04T11:00:10+00:00
Accession:  0001437749-26-025506
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals appoints Danka Radosavljevic as COO
--------------------------------------------------------

- Danka Radosavljevic appointed COO effective July 31, 2026; previously EVP of Operations since 2017.
- Annual base salary set at $520,800; discretionary bonus target of 50% of base salary.
- Radosavljevic oversaw quality, product development, regulatory, supply chain, and IT in prior role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774926025506/0001437749-26-025506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774926025506/eton20260731_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-025506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer